Outcomes of tocilizumab and sarilumab for hospitalized patients with COVID-19: retrospective study
Abstract Introduction Tocilizumab (TZ) and sarilumab (SL), IL-6 receptor antagonists, were utilized during the pandemic, yet direct comparisons remain limited, particularly in resource-constrained settings facing drug shortages. Hypothesis This study aimed to evaluate whether TZ and SL yield compara...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-06-01
|
| Series: | The Egyptian Journal of Bronchology |
| Online Access: | https://doi.org/10.1186/s43168-025-00423-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|